The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual “window of treatment success” in RA patients

BACKGROUND: There is a need for biomarker to identify patients “at risk” for rheumatoid arthritis (risk-RA) and to better predict the therapeutic response and in this study we tested the hypothesis that novel native and citrullinated heterogeneous nuclear ribonucleoprotein (hnRNP)-DL autoantibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Marklein, Bianka, Jenning, Madeleine, Konthur, Zoltán, Häupl, Thomas, Welzel, Franziska, Nonhoff, Ute, Krobitsch, Sylvia, Mulder, Debbie M., Koenders, Marije I., Joshua, Vijay, Cope, Andrew P., Shlomchik, Mark J., Anders, Hans-Joachim, Burmester, Gerd R., Hensvold, Aase, Catrina, Anca I., Rönnelid, Johan, Steiner, Günter, Skriner, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439038/
https://www.ncbi.nlm.nih.gov/pubmed/34521462
http://dx.doi.org/10.1186/s13075-021-02603-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439038/
https://www.ncbi.nlm.nih.gov/pubmed/34521462
http://dx.doi.org/10.1186/s13075-021-02603-x

Ejemplares similares